Letter to the editor: Circulating thrombospondin-2 as a biomarker in patients with NAFLD with and without diabetes-Are we convinced yet? Lee CH, Lui DTW, Lam KSL. Hepatology 2022;75:1340.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee CH, Lui DTW, Lam KSL. Letter to the editor: Circulating thrombospondin-2 as a biomarker in patients with NAFLD with and without diabetes-Are we convinced yet? Hepatology 2022;75:1340.
PMID: 35075677